-
Information
iCFO Information Booth How can we help? -
EntrepreneurCreative BioTherapeutics WE START WHERE OTHER THERAPIES FAIL FOR RECURRENT & DRUG RESISTANT CANCERS
-
EntrepreneurGel Dynamics A Vetted Solution With A Global Market
-
EntrepreneurSovány Beverage Sovany is more than just another organic sparkling water
-
EntrepreneurAddimmune Addimmune’s sole purpose is to cure HIV. We believe it’s possible with gene and cell therapy.
Join us next time to meet Noel Greenberger!
Nob Hill Therapeutics is a healthcare startup that is developing new technologies and therapies for lung-related diseases that can’t be effectively treated today. These diseases impact millions of patients, and the annual market potential for several of these diseases is substantial (e.g., lung cancer - $30b, Cystic Fibrosis - $13b, Invasive fungal infections - $9b). Nob Hill has developed a new drug inhalation device platform that solves many disadvantages with today’s technologies and also is working on accompanying drug-device combination products that will serve as PoC for the technology (with addressable markets in the US of $1.75b annual sales). Nob Hill’s team is highly experienced with developing and commercializing respiratory products (combined experience of 100+ years).
